Topical Tenofovir, a Microbicide Effective against HIV, Inhibits Herpes Simplex Virus-2 Replication-Reference-Cited by-同舟云学术

Topical Tenofovir, a Microbicide Effective against HIV, Inhibits Herpes Simplex Virus-2 Replication

Published:2011-10 Issue:4 Volume:10 Page:379-389
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Andrei Graciela,Lisco Andrea,Vanpouille Christophe,Introini Andrea,Balestra Emanuela,van den Oord Joost,Cihlar Tomas,Perno Carlo-Federico,Snoeck Robert,Margolis Leonid,Balzarini Jan

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference34 articles.

1. Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials;Abdool Karim;Future Microbiol.,2010

2. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women;Abdool Karim;Science,2010

3. Molecular Biology of the Cell;Alberts,1994

4. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene;Andrei;J. Gen. Virol.,2000

5. Organotypic epithelial raft cultures as a model for evaluating compounds against alphaherpesviruses;Andrei;Antimicrob. Agents Chemother.,2005

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention;The Journal of Infectious Diseases;2024-04-24

2. Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma;Journal of Pharmacology and Experimental Therapeutics;2023-10-24

3. Tenofovir vaginal film as a potential MPT product against HIV-1 and HSV-2 acquisition: formulation development and preclinical assessment in non-human primates;Frontiers in Reproductive Health;2023-08-10

4. A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir;Frontiers in Cellular and Infection Microbiology;2023-04-19

5. Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention;Frontiers in Immunology;2022-12-06